Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards

Life Health > Health Insurance > Health Insurance

Bird flu strain spreads to human

Your article was successfully shared with the contacts you provided.

LONDON (AP) — A strain of bird flu that scientists thought could not infect people has shown up in a Taiwanese woman.

The case is a nasty surprise that shows scientists must do more to spot worrisome flu strains before they ignite a global outbreak, doctors say.

On a more hopeful front, two pharmaceutical companies separately reported encouraging results from human tests of a possible vaccine against a different type of bird flu. The other strain of bird flu that has been spreading in China. Some fear that strain could cause a pandemic, or severe, international flu epidemic.

The woman in Taiwan, 20, was hospitalized in May with a lung infection. After being treated with Tamiflu and antibiotics, she was released. One of her throat swabs was sent to the Taiwan Centres for Disease Control. Experts there identified it as the H6N1 bird flu, which has been circulating in chickens on Taiwan.

The patient, who was not identified, worked in a deli and had no known connection to live birds. Investigators couldn’t figure out how she was infected. They noted that several of her close family and friends also developed flu-like symptoms after spending time with her, though none tested positive for H6N1. The research was published online Thursday in the journal Lancet Respiratory Medicine.

Since the H5N1 bird flu strain first broke out in southern China in 1996, public health officials have been nervously monitoring its progress — it has so far killed more than 600 people, mostly in Asia. Several other bird flu strains, including H7N9, which was first identified in China in April, have also caused concern, but, so far, none has mutated into a form able to spread easily between people.

“The question again is what would it take for these viruses to evolve into a pandemic strain?” wrote Marion Koopmans, a virologist at the National Institute for Public Health and the Environment in the Netherlands, in a commentary accompanying the new report.

She said it was worrying that scientists had no early warning signals that such new bird flus could be a problem until humans actually fell ill.

Scientists often monitor birds to see which viruses are killing them, in an attempt to guess which flu strains might be troublesome for humans — but neither H6N1 nor H7N9 makes birds very sick.

Koopmans called for increased surveillance of animal flu viruses and more research into predicting which viruses might cause a global crisis.

“We can surely do better than to have human beings as sentinels,” she wrote.

The vaccine news is on the H7N9 bird flu. That strain has infected at least 137 people and killed at least 45 since last spring.

Scientists from Novavax Inc., a Gaithersburg, Maryland, company, say tests on 284 people suggest that, after getting two shots of an experimental vaccine, most of the patients made antibodies at a level that usually confers protection.

“They gave a third of the usual dose and yet had antibodies in over 80 percent,” said an expert not connected with the work, Dr. Greg Poland of the Mayo Clinic. “This is encouraging news. We’ve struggled to make vaccines quickly enough against novel viruses.”

Results were published online Wednesday by the New England Journal of Medicine.

In another announcement, Switzerland-based Novartis announced today that early tests on its H7N9 vaccine on 400 people showed that two does produced a protective immune response in 85 percent.

The Novartis data has not yet been published.

AP Chief Medical Writer Marilynn Marchione contributed to this report from Milwaukee.

See also:


© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.